Evidence map›Paper›PMID 36720958›Full record

ArticleScientific reports2023

CID12261165, a flavonoid compound as antibacterial agents against quinolone-resistant Staphylococcus aureus.

Yuh Morimoto, Yoshifumi Aiba, Kazuhiko Miyanaga, Tomomi Hishinuma, Longzhu Cui, Tadashi Baba, Keiichi Hiramatsu

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Phytochemical Constituent of Devil Weed (Molecules (Basel, Switzerland) · 2025
    Article
  9. Bioactivity-Guided Isolation of Flavone Glycoside fromMolecules (Basel, Switzerland) · 2025
    Article
  10. Review
  11. Review
  12. Antibacterial activity of baicalein againstFrontiers in microbiology · 2025
    Article
  13. The fitness connection of antibiotic resistance.Frontiers in microbiology · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Yuh MorimotoDepartment of Radiological Technology, Faculty of Health Science, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Yoshifumi AibaDivision of Bacteriology, Jichi Medical School, 3311-1 Yakushiji, Shimotsuke-shi, Tochigi, 329-0498, Japan.
Kazuhiko MiyanagaDivision of Bacteriology, Jichi Medical School, 3311-1 Yakushiji, Shimotsuke-shi, Tochigi, 329-0498, Japan.
Tomomi HishinumaDepartment of Microbiology, School of Medicine, Juntendo University, Tokyo, Japan.
Longzhu CuiDivision of Bacteriology, Jichi Medical School, 3311-1 Yakushiji, Shimotsuke-shi, Tochigi, 329-0498, Japan.
Tadashi BabaGraduate School of Nursing, Seisen Jogakuin College, 2277 Kurita, Nagano, 380-0921, Japan. t.baba@sjc-nagano.ac.jp.
Keiichi HiramatsuJuntendo University Center of Excellence for Infection Control Science, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Jichi Medical University · JPJuntendo University · JPSeisen Jogakuin College · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Flavonoids are plant-produced secondary metabolites that are found ubiquitously. We have previously reported that apigenin, a class of flavonoid, has unique antimicrobial activity against Staphylococcus aureus (S. aureus), one of the major human pathogens. Apigenin inhibited fluoroquinolone-resistant S. aureus with DNA gyrase harboring the quinolone-resistant S84L mutation but did not inhibit wild-type DNA gyrase. In this study, we describe five flavonoids, quercetin, luteolin, kaempferol, baicalein, and commercially available CID12261165, that show similar antimicrobial activity against fluoroquinolone-resistant S. aureus. Among them, CID12261165 was the most effective with MIC values of ≤ 4 mg/L against quinolone-resistant S. aureus strains. In vitro DNA cleavage and supercoiling assays demonstrated inhibitory activity of CID12261165 against mutated DNA gyrase, whereas activity against wild-type DNA gyrase was not observed. CID12261165 also inhibited quinolone-resistant Enterococci with an MIC value of 8 mg/L. While fluoroquinolone-resistant amino acid replacements can improve the fitness of bacterial cells, it is unknown why quinolone-susceptible S. aureus strains were predominant before the introduction of fluoroquinolone. The present study discusses the current discrepancies in the interpretation of antimicrobial activities of flavonoids, as well as the possible reasons for the preservation of wild-type DNA gyrase wherein the environmental flavonoids cannot be ignored.

Indexed as

FlavonoidsFluoroquinolonesStaphylococcus aureusAnti-Bacterial AgentsApigeninDNA GyraseDrug Resistance, BacterialAnti-Bacterial AgentsApigeninDNA GyraseFlavonoidsFluoroquinolones

Identifiers

PMID36720958
PMCPMC9889749
OpenAlexW4318616221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.